4,4'-Divinyl-1,1'-biphenyl, 95% mix TBC as stabilizer, 250mg

2-(1H-PYRAZOL-3-YL)ETHANOL, 95.0%, 250mg

2-Bromo-2-(4-chlorophenyl)acetic acid, 95.0%, 1g

Heparin sodium salt, min. 180 IU/mg, Ph.Eur., from porcine intestinal mucosa, 1 g

N-Ethylglycine>98.0%(T)25g

rel-1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4r)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,4-dihydroisoquinolin-3(2H)-one, 98%, 25mg

ETHYL 5-([(TERT-BUTOXY)CARBONYL]AMINO)-6-METHYLPYRIDINE-3-CARBOXYLATE, 95.0%, 500mg

2,7-Dibromo-9-heptyl-9H-carbazole>98.0%(GC)1g

Magnetic stirring bars ROTILABO® elliptical, , 10 mm, 30 mm, 1 piece

Methyl 4-amino-2-methyl-5-nitrobenzoate, 95.0%, 1g

2-METHYL-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXYLIC ACID, 95%, 10g

Methyl 3-amino-5-fluoro-2-methylbenzoate, 97%, 5g

3-Bromo-7-iodoquinoline, 98.0%, 250mg